05/11/2014

Newsletter

Senology

Newsletter del 6 Novembre 2014
SEGUICI SU
Direttore Editoriale: Gian Paolo Andreoletti, MD
Editoriale
Timing della ricostruzione mammaria in rapporto al trattamento radioterapico
"Timing of breast reconstruction and radiotherapy in women ...
rassegna stampa
Efficacia del trastuzumab nella terapia adiuvante del carcinoma mammario HER2 positivo in stadio iniziale
Addition of trastuzumab to paclitaxel after doxorubicin and cyclophosphamide in early–stage HER2–positive breast cancer linked to improvement in survival
Stato dei recettori ormonali e rischio di secondo tumore mammario primitivo controlaterale
Women with HR-negative first primary breast cancer have elevated risk of contralateral second primary breast cancer
Radioterapia o chirurgia dell'ascella in donne con carcinoma mammario e positività del linfonodo sentinella
Comparable axillary control with radiotherapy or surgery of the axilla after a positive sentinel node in women with breast cancer
Radioterapia ipofrazionata dopo mastectomia in pazienti con tumore mammario in fase iniziale
High local control rate and acceptable toxicity with hypofractionated RT following mastectomy in early breast cancer
Livelli di proteina C-reattiva preoperatoria e prognosi del carcinoma mammario in pazienti senza interessamento tumorale linfonodale
Pre-operatively elevated C-reactive protein levels at time of diagnosis are linked to shorter survival in node-negative breast cancer patients
Mastectomia con risparmio della cute e del complesso areola-capezzolo nel carcinoma mammario
Skin and nipple-areola complex sparing mastectomy is a safe procedure for breast cancer with low recurrence risk
Radioterapia dopo chirurgia conservativa per carcinoma duttale in situ
Radiotherapy after breast-conserving surgery for ductal carcinoma in situ is associated with modest protection against recurrences and possible increase in contralateral cancers
Alterazioni del ritmo circadiano e tumore mammario
Circadian disruption is associated with an increased breast cancer risk in women
Esercizio fisico e rischio cardiovascolare in pazienti trattati per linfoma di Hodgkin
Vigorous exercise is linked to lower risk of cardiovascular events in adult survivors of childhood Hodgkin lymphoma
Le nuove linee guida canadesi sconsigliano l'uso del PSA per lo screening del tumore prostatico
Canadian Task Force on Preventive Health Care: no evidence that PSA screening reduces overall mortality among men of any age
Assunzione giornaliera di aspirina e prognosi del carcinoma prostatico
Postdiagnosis daily aspirin is linked to lower prostate cancer–specific mortality in men with high-risk prostate cancer
Numero ottimale di cicli di chemioterapia con derivati del platino in pazienti con carcinoma polmonare non a piccole cellule
Six cycles of first-line platinum-based chemotherapy are not linked to higher survival compared with three or four cycles in patients with advanced non-small-cell lung cancer
Radioterapia dei linfonodi paraaortici e rischio di diabete in pazienti con linfoma di Hodgkin
Radiation to para-aortic lymph nodes increases the risk of diabetes in long-term survivors of Hodgkin lymphoma
eventi
Late and later relapses and sequelae: the dilemma of endocrine treatment duration, compliance and treatment tailoring
10th Meet the Professor. Advanced International Breast Cancer Conference (AIBCC) - con il Patrocinio di Senology
The data in our possesion is done in according with law 675/96.
If this e-mail has reached you in error, simply click on the following link and unsubscribe yourself.
Copyright 2010 A&B Snc Edizioni Medico Scientifiche. All rights reserved. P.Iva 02307560169
SUBSCRIBE | UNSUBSCRIBE | CONTATTI

Condividi
Altri articoli

Newsletter

Condividi

Newsletter

Condividi

Newsletter

Condividi

Newsletter

Condividi

Newsletter

Condividi